[1] 王彬,李槐.胰腺癌的综合治疗[J].中国介入影像与治疗学,2007,4(2):154-158.
[2] 王凯,石欣,黄毅,等.肿瘤标志物对胰腺癌诊断的研究进展[J].东南大学学报:医学版,2011,30(5):793-796.
[3] 张太平,杜潇,赵玉沛.多学科综合治疗胰腺癌现状及评价[J].中国实用外科杂志,2009,29(9):771-773.
[4] 黄毅,石欣,黄聪,等.血管内皮生长因子单克隆抗体抗胰腺癌的机制及临床前的研究进展[J].东南大学学报:医学版,2011,30(5):784-788.
[5] SENER S F,FREMGEN A,MENCK H R,et al.Pancreatic Ⅲ ceIare ort of treatment and survival trends for 100,313 patients diagnosed from 1985-1995,using the National Cancer Database[J].J Am Coil Surg,1999,189(1):1-7.
[6] JEMAL A,SIEGEL R,WARD E,et al.Cancer statistics[J].CA Cancer J Clin, 2007,40(4):139-141.
[7] COHENURAM M,SAIF M W.Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present, and the future[J].JOP,2007,33(7):33-37.
[8] KONDO N,MURAKAMI Y,UEMURA K,et al.Patients treated with adjuvant gemcitabine plus S-1 chemotherapy after surgical resection[J].Ann Surg Oncol,2012,8(5):143-148.
[9] JOHNSON J,de Mejia E G.Dietary factors and pancreatic cancer: the role of food bioactive compounds[J].Mol Nutr Food Res,2011,55(1):58-73.
[10] NÖTHLINGS U,MURPHY S P,WILKENS L R,et al.Flavonols and pancreatic cancer risk the multiethnic cohort study[J].Am J Epidemiol,2007,166(8):924-931.
[11] ROSSI M,LUQO A,LAQIOU P,et al.Proanthocyanidins and other flavonoids in relation to pancreatic cancer: a case-control study in Italy[J].Ann Oncol,2012,23(6):1488-1493.
[12] KING J C,LU Q Y,LI G,et al. Evidence for activation of mutated p53 by apigenin in human pancreatic cancer[J].Biochim Biophys Acta, 2012,1823(2):593-604.
[13] DING C,KHAN M,ZHENG B,et al.Casticin induces apoptosis and mitotic arrest in pancreatic carcinoma PANC-1 cells[J].Afr J Pharm Pharmaco,2012,6(6):412-418.
[14] JIAN D U, TANG B.Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells[J].Int J Mol Med,2012,29(4):607-612.
[15] THAKUR V S,GUPTA K,GUPTA S,et al.The Chemopreventive and chemotherapeutic potentials of tea polyphenols[J].Curr Pharm Biotechnol,2012,13(1):191-199.
[16] KOTAMBALLI N,CHIDAMBARA M. Apoptosis mediated cytotoxicity of citrus obacunone in human pancreatic cancer cells[J].Toxicol in Vitro,2011,25(4):859-867.
[17] ZHANG Y Q,CHEN A Y,LI M,et al.Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells[J].J Surg Res, 2008,148(1):17-23.
[18] Phillips P A,SANGWAN V,BORJA-CACHO D,et al.Myricetin induces pancreatic cancer cell death via the inductionof apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K)signaling pathway[J].Cancer Letters,2011,308(2):181-188.
[19] MURTAZA I,ADHAMI V M,HAFEEZ B B,et al.Fisetin, a natural flavonoid, targets chemoresistant humanpancreatic cancer AsPC-1 cells through DR3 mediated inhibitionof NF-κB[J].Int J Cancer,2010,125(10):2465-2473.
[20] ZHANG B,SHI Z L,LIU B,et al.Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: the role of Akt and nuclear factor-kappaB[J].Anticancer Drugs,2010,21(3):288-296.
[21] WANG Z,DESMOULIN S,BANERJEE S,et al.Synergistic effects of multiple natural products in pancreatic cancer cells[J].Life Sciences,2008,83(7-8):293-300.
[22] TANG S N,FU J,SHANKAR S,et al.EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer[J].PloS One,2012,7(2):e31067.
[23] VITTORIO O,CIRILLO G,lEMMA F,et al. Dextran-catechin conjugate: a potential treatment against the pancreatic ductal adenocarcinoma[J].Pharm Res,2012,29(9):2601-2614.
[24] UJIKI M B,DING X Z,SALABAT M R,et al.Apigenin inhibits pancreatic cancer cell proliferation through G2/Mcell cycle arrest[J].Molecular Cancer,2006,29(5):76-81.
[25] MADDIKA S,ANDE S R,PANIGRAHI S,et al. Drug Resist[J].Updat,2007,10(1-2):13-29.
[26] JUNG C P,MOTWANI M V,SCHEARTZ G K.Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates withdown-regulation of ribonucleotide reductase M2 subunit[J].Clin Cancer Res,2001,7(8):2527-2536.
[27] TANG S N,F U J,NALL D,et al.Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics[J].Int J Cancer,2012,131(1):30-40.
[28] BORSKA S,DRAG-ZALESINSKA M,WYSOCKA T,et al.Antiproliferative and pro-apoptotic effects of quercetinon human pancreatic carcinoma cell lines EPP85-181Pand EPP85-181RDB[J].Folia Histochem Cyto, 2010,48(2):222-229.
[29] ADIKRISNA R,TANAKA S,MURAMATSU S,et al.Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents[J].Gastroenterology,2012,143(1):234-245.
[30] HARRIS D M,LI L,CHEN M,et al.Diverse mechanisms of growth inhibition by luteolin, resveratrol,and quercetin in MIA PaCa-2 cells:a comparative glucose tracerstudy with the fatty acid synthase inhibitor C75[J].Metabolomics,2012,8(2):201-210.
[31] OI N,JEONG C H,NADAS J,et al.Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A4 hydrolase[J].Cancer Res,2010,70(23):9755-9764. |
